The Clinical Enigma of Cardiogenic Shock
Program Goals
Prevalence of Cardiogenic Shock
Clinical Scenario
Prompt Revascularization and Hemodynamic Support
Diagnosis and Classification
Signs and Symptoms of CS
CS Frequency, Trends, and Risk
Vasopressors vs Inotropes for Improvement in Organ Perfusion
SOAP II Trial – Norepinephrine vs Dopamine
Treatment Algorithm for Cardiogenic Shock
Potential CS Care Pathway
Device Selection
Types of pMCS Devices
Temporary pMCS vs Durable MCS
CS Center Characteristics
Reperfusion Strategy Selection
Delayed Implementation of Effective Therapies for Shock
The Role of Early RHC in CS Patients
Guideline Recommendations for Circulatory Support in Cardiogenic Shock
Prioritizing Lesion Revascularization
The Shock Team
Take Home Points
Conclusion
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
Abbreviations (cont)